DOCSLIB.ORG

Analysis of Phosphorylated STAT Protein Signaling in Lymphocytes Using Flow Cytometry

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Analysis of Phosphorylated STAT Protein Signaling in Lymphocytes Using Flow Cytometry Application Note Cell Analysis Analysis of Phosphorylated STAT Protein Signaling in Lymphocytes Using Flow Cytometry Author Abstract Agilent Technologies, Inc. This application note examines the phosphorylation of signal transducer and activator of transcription (STAT) proteins in response to cytokine stimulation using a flow cytometry–based phosphoflow technique and the Agilent NovoCyte flow cytometer. The results demonstrate the efficacy of this approach for the rapid, quantitative, scalable, and multiparameter detection of phosphorylated protein in single cells. Introduction many cellular events including T and blotting, and mass spectrometry. B cell signaling, cell metabolism, cell Western blotting is the most commonly Protein phosphorylation is the growth, apoptosis, and other processes. used but has shortcomings; it is biological process of transferring semiquantitative, time-consuming, and Cytokines are a group of small a phosphate group to a substrate requires a large amount of starting secreted proteins important for protein, which primarily occurs on material. Also, cell separation may be immune cell-to-cell communication, tyrosine, serine, and threonine residues. required to isolate a pure population of a immune cell activation, differentiation, Protein phosphorylation can cause cells from a heterogeneous mixture. conformational changes, changes and migration towards the site of Analysis of phosphorylated proteins by in protein activity, or protein-protein inflammation/infection. Cytokines bind to flow cytometry or phosphoflow was interactions. This event can also initiate receptors on the cell surface and activate first described in the early 2000s. By a phosphorylation signaling cascade intracellular cascades, such as the Janus combining a phosphoflow methodology leading to a sequence of protein kinase (JAK)/STAT pathway. STATs are with cell surface antibody staining, rare phosphorylation events. the final phosphorylated protein in this cascade; they translocate to the nucleus cell populations can be studied in the This produces an assortment of kinases and alter gene expression. There are presence of other cell types. Multiple and phosphatases, which regulate many methods for detecting intracellular cell types can also be analyzed in intracellular protein phosphorylation. protein phosphorylation, including one sample. Protein phosphorylation is crucial for radiometric kinases assays, western 1.1 105 105.5 A 309.2 1.0 240 104 ) ) 3 6 0.8 4 0 0 10 180 0.6 120 CD16 PE-H FSC-A (1 SSC-H (1 CD19 APC-H 3 10 3 0.4 10 60 0 0 0 0.2 -103 -103 0.1 0.4 0.8 1.2 1.6 2.0 2.3 0.1 0.4 0.8 1.2 1.6 2.0 2.3 -102 103 104 105 -102 103 104 105 FSC-H (106) FSC-H (106) CD3 Pacific Blue-H CD3 Pacific Blue-H B T cells CD3+ B cells CD19+ NK cells CD16+ C Medians fold-change 25 T cells B cells 0 12.525 NK cells 20 unstim 1 min. 15 2 min. 5(pY694) 4 min. AT 10 ST 8 min. 12 min. 5 16 min. -103 103 104 105 -103 103 104 105 -103 103 104 105 p-stat5 Ax647-H p-stat5 Ax647-H p-stat5 Ax647-H 0 0 10 20 Time of stimulation (min) Figure 1. Time-dependent differences in IL-2–induced STAT5 phosphorylation among lymphocyte subsets. PBMCs were isolated from the blood of a healthy donor. Cells were stained with αCD19 FITC antibody before IL-2 stimulation. PBMCs were then stimulated with 100 ng/mL IL-2 for 0 to 16 minutes at 37 °C. After cytokine stimulation, cells were fixed in 1.5% paraformaldehyde for 10 minutes at room temperature and pelleted by centrifugation. Thereafter, cells were permeabilized with ice cold 100% methanol for 15 minutes. Finally, cells were stained with αCD16 PE, αCD3 Pacific Blue, and α-p-STAT5 AlexaFluor647 for one hour. The main cell population was identified by FSC-H and SSH-H. Single cells were than identified in the FSC-H and FSC-A plot to eliminate doublets. Cell surface stains identified the lymphocyte populations: CD19 B cells, CD3 T cells, and CD16 NK Cells. Data were analyzed using the CytoBank website for histogram overlay and heat map analysis (B). Changes in p-STAT5 expression were graphed as the fold change/time compared to the unstimulated sample for each lymphocyte population (C). 2 IL-2 induces potent cellular structure. This was followed by any indications of response, even when measured at the longest time point. Both p-STAT5 signaling in T and permeabilization with 100% methanol to allow the phospho-specific antibodies T cells and NK cells responded rapidly, NK but not B lymphocyte to stain inside the cell. Surface stains showing a 4.5- and 3.2-fold increase, cell populations identified specific population of respectively, in p-STAT5 levels within one lymphocytes: CD19 for B cells, CD3 minute of IL-2 addition. The phosphorylation of STAT5 in for T cells, and CD16 for Natural Killer Although time-dependent increases were peripheral blood mononuclear cells (NK) cells as shown in the sample sustained in T cells, no further increases (PBMCs) when induced by IL-2 was gating plots (Figure 1). Since the CD19 in p-STAT5 were seen in NK cells investigated to examine B, T, and NK epitope was destroyed upon exposure to after eight minutes. This result can be lymphocyte cell populations. The degree formaldehyde, the PBMCs were stained explained by the differential expression of phosphorylation was determined by with αCD19 antibody before cytokine of IL-2 receptors in lymphocyte phosphoflow, in which a phosphorylated stimulation. populations, as B cells express relatively protein-specific antibody is used to PBMCs were treated with 100 ng/mL few IL-2 receptors compared to T and determine the levels of p-STAT5 (Y694). of IL-2 from 0 to 16 minutes, stained NK cells. IL-2 receptor expression PBMCs were either stimulated with IL-2 for p-STAT5, and then analyzed on the is especially high in activated T cell or IL-4 for a varying amount of time or NovoCyte flow cytometer (Figure 1). populations that are particularly reliant concentration of cytokine. Following a p-STAT5 levels varied greatly in T, B, and on IL-2 signaling for cell survival and typical fixation/permeabilization protocol NK cell populations. Both T and NK cells proliferation. for phosphoflow, cells were first fixed in responded, while B cells did not show 1.5% paraformaldehyde to stabilize the A T cells C3 B cells C19 NK cells C16 B 30 edians fold-change T cells 0 12.5 25 25 N cells 20 unstim 0.006 ngm 15 0.032 ngm 0.16 ngm 10 0.8 ngm 4 ngm median fold-change STAT5p694 5 20 ngm 0 100 ngm 0 -2 -1 0 1 2 3 4 og10I-2 ngm 500 ngm -103 103 104 105 -103 103 104 105 -103 103 104 105 p-STAT5 A64- p-STAT5 A64- p-STAT5 A64- Figure 2. Dose-response analyses reveal differences in IL-2–induced STAT5 phosphorylation among lymphocyte subsets. PBMCs were isolated and stained with αCD19 FITC, as described in Figure 2. Cells were stimulated with IL-2 at a concentration of 0 to 500 ng/mL for 15 minutes. PBMCs were then fixed and permeabilized, as described in Figure 2. Data was analyzed using the tools provided by the CytoBank website for histogram overlay and heat map analysis of p-STAT5 phosphorylation results (A). Changes in p-STAT5 expression were then recorded as fold change compared to unstimulated sample, with increasing concentration of IL-2 for the T and NK cell population (B). EC50 values of STAT5 phosphorylation of T and NK cells were determined by Prism 6 software. B cells were not graphed as they did not respond to IL-2 stimulation. 3 Next, the phosphorylation of STAT5's IL-4 induces robust p-STAT6 expression at the Y641 residue dose-dependent response to IL-2 in in T, B, and NK cell populations (Figure 3). PBMCs was investigated. Cells were p-STAT6 signaling in All lymphocyte populations responded to treated with 0 to 500 ng/mL of IL-2 all lymphocyte cell IL-4, but B cells were the most sensitive, for 15 minutes followed by p-STAT5 displaying a significant increase in analysis in each lymphocyte subset populations p-STAT6 with as little as 0.16 ng/mL of (Figure 2). A stronger dose-dependent IL-4 is another important cytokine in IL-4. No significant increase was seen in response for T cells was observed than the immune response vital for T cell T and NK cells until IL-4 concentration that of NK cells. While NK cells did not differentiation, immunoglobulin class reached 4 ng/mL. respond to increases in IL-2 after a switching in B cells, and alternative The p-STAT6 response in B cells also concentration of 20 ng/mL, increases in macrophage activation. IL-4 is primarily became saturated at a much lower p-STAT5 levels in T cells were seen at the secreted by activated T cells, basophils, concentration of IL-4 (20 ng/mL), while highest concentration tested, 500 ng/mL; and mast cells. IL-4 signaling results in in T and NK cells, the saturation of the calculated EC50 values of STAT5 a rapid increase in phosphorylation of p-STAT6 abundance was observed up phosphorylation of IL-2 stimulated T cells STAT6 and plays an important role in to 100 ng/mL. This was underscored and NK cells were 21.57 ng/mL and 3.89 the adaptive immune response of helper by the EC50 values calculated for ng/mL, respectively (Figure 2B). The T cells and B cells. the lymphocyte populations: B cells observed by p-STAT5 analysis by flow 2.58 ng/mL, T cells 17.51 ng/mL, and cytometry showed that T cells respond In this next experiment, we examined the NK cells 19.39 ng/mL (Figure 3B).
Load more

Recommended publications
  • Targeting Il13ralpha2 Activates STAT6-TP63 Pathway to Suppress Breast Cancer Lung Metastasis Panagiotis Papageorgis1,2,3*, Sait Ozturk2, Arthur W
    Papageorgis et al. Breast Cancer Research (2015) 17:98 DOI 10.1186/s13058-015-0607-y RESEARCH ARTICLE Open Access Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis Panagiotis Papageorgis1,2,3*, Sait Ozturk2, Arthur W. Lambert2, Christiana M. Neophytou1, Alexandros Tzatsos4, Chen K. Wong2, Sam Thiagalingam2*† and Andreas I. Constantinou1*† Abstract Introduction: Basal-like breast cancer (BLBC) is an aggressive subtype often characterized by distant metastasis, poor patient prognosis, and limited treatment options. Therefore, the discovery of alternative targets to restrain its metastatic potential is urgently needed. In this study, we aimed to identify novel genes that drive metastasis of BLBC and to elucidate the underlying mechanisms of action. Methods: An unbiased approach using gene expression profiling of a BLBC progression model and in silico leveraging of pre-existing tumor transcriptomes were used to uncover metastasis-promoting genes. Lentiviral- mediated knockdown of interleukin-13 receptor alpha 2 (IL13Ralpha2) coupled with whole-body in vivo bioluminescence imaging was performed to assess its role in regulating breast cancer tumor growth and lung metastasis. Gene expression microarray analysis was followed by in vitro validation and cell migration assays to elucidate the downstream molecular pathways involved in this process. Results: We found that overexpression of the decoy receptor IL13Ralpha2 is significantly enriched in basal compared with luminal primary breast tumors as well as in a subset of metastatic basal-B breast cancer cells. Importantly, breast cancer patients with high-grade tumors and increased IL13Ralpha2 levels had significantly worse prognosis for metastasis-free survival compared with patients with low expression.
    [Show full text]
  • Signal Transducer and Activator of Transcription 5A/B in Prostate and Breast Cancers
    Endocrine-Related Cancer (2008) 15 367–390 REVIEW Signal transducer and activator of transcription 5A/B in prostate and breast cancers Shyh-Han Tan and Marja T Nevalainen Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, BLSB 309, Philadelphia, Pennsylvania 19107, USA (Correspondence should be addressed to M T Nevalainen; Email: [email protected]) Abstract Protein kinase signaling pathways, such as Janus kinase 2-Signal transducer and activator of transcription 5A/B (JAK2-STAT5A/B), are of significant interest in the search for new therapeutic strategies in both breast and prostate cancers. In prostate cancer, the components of the JAK2- STAT5A/B signaling pathway provide molecular targets for small-molecule inhibition of survival and growth signals of the cells. At the same time, new evidence suggests that the STAT5A/B signaling pathway is involved in the transition of organ-confined prostate cancer to hormone- refractory disease. This implies that the active JAK2-STAT5A/B signaling pathway potentially provides the means for pharmacological intervention of clinical prostate cancer progression. In addition, active STAT5A/B may serve as a prognostic marker for identification of those primary prostate cancers that are likely to progress to aggressive disease. In breast cancer, the role of STAT5A/B is more complex. STAT5A/B may have a dual role in the regulation of malignant mammary epithelium. Data accumulated from mouse models of breast cancer suggest that in early stages of breast cancer STAT5A/B may promote malignant transformation and enhance growth of the tumor. This is in contrast to established breast cancer, where STAT5A/B may mediate the critical cues for maintaining the differentiation of mammary epithelium.
    [Show full text]
  • Expression of Androgen Receptor Coregulators in Prostate Cancer
    1032 Vol. 10, 1032–1040, February 1, 2004 Clinical Cancer Research Expression of Androgen Receptor Coregulators in Prostate Cancer Marika J. Linja,1 Kati P. Porkka,1 Conclusions: These findings suggest that the decreased Zhikang Kang,3 Kimmo J. Savinainen,1 expression of PIAS1 and SRC1 could be involved in the progression of prostate cancer. In addition, gene amplifica- Olli A. Ja¨nne,3 Teuvo L. J. Tammela,2 4 3 tion of SRC1 in one of the xenografts implies that, in some Robert L. Vessella, Jorma J. Palvimo, and tumors, genetic alteration of SRC1 may provide a growth 1 Tapio Visakorpi advantage. 1Laboratory of Cancer Genetics, Institute of Medical Technology and 2Department of Urology, University of Tampere and Tampere University Hospital, Tampere, Finland; 3Institute of Biomedicine, INTRODUCTION 4 University of Helsinki, Helsinki, Finland; and Department of The critical role of androgens in the development of pros- Urology, University of Washington, Seattle, Washington tate cancer is indicated, for example, by the fact that prostate cancer does not develop in men castrated early in their life (1). ABSTRACT In addition, more that 50 years ago, Huggins and Hodges (2) Purpose: The androgen receptor (AR)-mediated signal- showed that hormonal therapy is an effective treatment for ing pathway seems to be essentially involved in the develop- prostate cancer. Subsequently, androgen withdrawal has become ment and progression of prostate cancer. In vitro studies the standard and is practically the only effective treatment for have shown that altered expression of AR coregulators may advanced prostate cancer. Although most prostate carcinomas significantly modify transcriptional activity of AR, suggest- are originally androgen dependent, they eventually become hor- ing that these coregulators could also contribute to the mone refractory during treatment (3).
    [Show full text]
  • Interferons Inhibit Activation of STAT6 by Interleukin 4 in Human Monocytes by Inducing SOCS-1 Gene Expression
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 10800–10805, September 1999 Immunology Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression HAROLD L. DICKENSHEETS*, CHANDRASEKAR VENKATARAMAN†,ULRIKE SCHINDLER†, AND RAYMOND P. DONNELLY*‡ *Division of Cytokine Biology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892; and †Tularik, Inc., South San Francisco, CA 94080 Edited by William E. Paul, National Institutes of Health, Bethesda, MD, and approved July 8, 1999 (received for review February 16, 1999) ABSTRACT Interferons (IFNs) inhibit induction by IL-4 12), 15-lipoxygenase (15-LO) (13, 14), IL-1 receptor antago- of multiple genes in human monocytes. However, the mecha- nist (IL-1ra) (15–17), and types I and II IL-1 receptors (IL-1R) nism by which IFNs mediate this inhibition has not been (18, 19). Type I IFNs (IFN-␣ and IFN-␤) and type II IFN defined. IL-4 activates gene expression by inducing tyrosine (IFN-␥) inhibit IL-4͞IL-13-induced gene expression in mono- phosphorylation, homodimerization, and nuclear transloca- cytes and B cells. For example, IFN-␥ suppresses IgE synthesis tion of the latent transcription factor, STAT6 (signal trans- by IL-4-stimulated B cells (20–22). IFNs also inhibit IL-4- ducer and activator of transcription-6). STAT6-responsive induced CD23 expression in both B cells (23, 24) and mono- elements are characteristically present in the promoters of cytes (25, 26). Furthermore, IFN-␥ inhibits IL-4- and IL-13- IL-4-inducible genes. Because STAT6 activation is essential induced expression of 15-LO and IL-1ra in monocytes (13, 14, for IL-4-induced gene expression, we examined the ability of 27).
    [Show full text]
  • Materials Express
    Materials Express 2158-5849/2020/10/1836/010 Copyright © 2020 by American Scientific Publishers All rights reserved. doi:10.1166/mex.2020.1822 Printed in the United States of America www.aspbs.com/mex Upregulation of signal transducer and activator of transcription 4 promotes osteoblast activity by activating AMP-activated protein kinase based on cationic liposome transfection Tao Jiang1,4,†, Qingzhen Chen1,2,†,MinShao2,∗, Zhen Shen3, Gang Wang3, Qinsheng Wang2, and Zhenming Zeng2 1The Third Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, PR China 2Department of Orthopedics, The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510240, Guangdong, PR China 3The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, PR China 4 Department of Orthopedics, GuangdongIP: 192.168.39.151 Second Traditional On: Thu, Chinese 30 Sep Medicine 2021 19:20:15 Hospital, Guangzhou 510095, Guangdong, PR China Copyright: American Scientific Publishers Delivered by Ingenta Article ABSTRACT Activation of Protein Kinase AMP-Activated Catalytic Subunit Alpha (AMPK) is an important regulatory path- way for osteogenic differentiation. STAT4 acts as a transcriptional activity factor to regulate the transcription of many genes and is potentially a regulatory factor for AMPK transcription activity. To confirm the regulatory effect of STAT4 on AMPK and the effect of STAT4 on osteogenic differentiation, the promoter sequence of AMPK was analyzed via bioinformatics, the STAT4 overexpression vector was constructed and transfected into human osteoblast-like cells MG-63 by cationic liposome, fluorescence quantitative PCR (RT-qPCR) and western blotting technologies were used to detect the effect of STAT4 on the expression of AMPK.MTT and ALP activity assays were also used to verify the effect of STAT4 on the proliferation and maturation of osteoblasts by regulating AMPK expression.
    [Show full text]
  • Modulation of STAT Signaling by STAT-Interacting Proteins
    Oncogene (2000) 19, 2638 ± 2644 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Modulation of STAT signaling by STAT-interacting proteins K Shuai*,1 1Departments of Medicine and Biological Chemistry, University of California, Los Angeles, California, CA 90095, USA STATs (signal transducer and activator of transcription) play important roles in numerous cellular processes Interaction with non-STAT transcription factors including immune responses, cell growth and dierentia- tion, cell survival and apoptosis, and oncogenesis. In Studies on the promoters of a number of IFN-a- contrast to many other cellular signaling cascades, the induced genes identi®ed a conserved DNA sequence STAT pathway is direct: STATs bind to receptors at the named ISRE (interferon-a stimulated response element) cell surface and translocate into the nucleus where they that mediates IFN-a response (Darnell, 1997; Darnell function as transcription factors to trigger gene activa- et al., 1994). Stat1 and Stat2, the ®rst known members tion. However, STATs do not act alone. A number of of the STAT family, were identi®ed in the transcription proteins are found to be associated with STATs. These complex ISGF-3 (interferon-stimulated gene factor 3) STAT-interacting proteins function to modulate STAT that binds to ISRE (Fu et al., 1990, 1992; Schindler et signaling at various steps and mediate the crosstalk of al., 1992). ISGF-3 consists of a Stat1:Stat2 heterodimer STATs with other cellular signaling pathways. This and a non-STAT protein named p48, a member of the article reviews the roles of STAT-interacting proteins in IRF (interferon regulated factor) family (Levy, 1997).
    [Show full text]
  • STAT6-Dependent Fashion CCL23 Expression Is Induced by IL-4 in A
    CCL23 Expression Is Induced by IL-4 in a STAT6-Dependent Fashion Hermann Novak, Anke Müller, Nathalie Harrer, Claudia Günther, Jose M. Carballido and Maximilian Woisetschläger This information is current as of September 28, 2021. J Immunol 2007; 178:4335-4341; ; doi: 10.4049/jimmunol.178.7.4335 http://www.jimmunol.org/content/178/7/4335 Downloaded from References This article cites 47 articles, 20 of which you can access for free at: http://www.jimmunol.org/content/178/7/4335.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CCL23 Expression Is Induced by IL-4 in a STAT6-Dependent Fashion Hermann Novak, Anke Mu¨ller, Nathalie Harrer, Claudia Gu¨nther, Jose M. Carballido, and Maximilian Woisetschla¨ger1 The chemokine CCL23 is primarily expressed in cells of the myeloid lineage but little information about its regulation is available.
    [Show full text]
  • Allen Gao, M.D., Ph.D
    Allen Gao, M.D., Ph.D. Research/Academic Interests Dr. Gao’s research interests focus on understanding molecular mechanisms associated with progression of castration-resistant prostate cancer and metastasis to bone with the goal of identification of potential therapeutic targets for prostate cancer. Particular emphasis includes microRNAs, aberrant androgen receptor activation by cytokines and transcriptional factors such as Stat3 and NF-kB, targeting cell signaling pathways (AR, IL-6 and Stat3), and mechanisms of drug resistance in prostate cancer. Dr. Gao’s lab was among the first to find that selenium regulates androgen signaling and that IL-4 activates the androgen receptor mediated by NF-B and Stat6, made the discovery that IL-6 signaling in prostate cancer involves Stat3, defined Stat3 and NF-B interactions in prostate cancer, discovered niclosamide as a novel inhibitor of androgen receptor variants (AR-V7), and identified several novel resistance mechanisms to enzalutamide/abiraterone/docetaxel including p52, IL- 6/Stat3, intracrine androgens/AKR1C3, and ABCB1. Dr. Gao has published over 100 peer-reviewed articles in the area of prostate cancer. His research findings such as the discovery of niclosamide as a novel inhibitor of androgen receptor variants have translated into several clinical trials (NCT02807805, NCT03123978) that test the combination treatments with current therapies to advanced resistant prostate cancer. Another recent discovery of indomethacin as an inhibitor of AKR1C3 and synergizing enzalutamide has also translated into clinical trial (NCT02935205) to test the combination treatments with current therapies to advanced resistant prostate cancer. Dr. Gao has served numerous NIH, NCI, DOD and VA merits, and American Cancer Society (ACS) review panels including SPORE and PPG study sections.
    [Show full text]
  • STAT6 Nuclear Trafficking Live Cell Imaging Reveals Continuous
    Live Cell Imaging Reveals Continuous STAT6 Nuclear Trafficking Hui-Chen Chen and Nancy C. Reich This information is current as J Immunol 2010; 185:64-70; Prepublished online 24 May of September 24, 2021. 2010; doi: 10.4049/jimmunol.0903323 http://www.jimmunol.org/content/185/1/64 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/05/21/jimmunol.090332 Material 3.DC1 References This article cites 42 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/185/1/64.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 24, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Live Cell Imaging Reveals Continuous STAT6 Nuclear Trafficking Hui-Chen Chen and Nancy C. Reich The STAT6 transcription factor is essential for the development of protective immunity; however, the consequences of its activity can also contribute to the pathogenesis of autoimmune disease.
    [Show full text]
  • Interpretation of Cytokine Signaling Through the Transcription Factors STAT5A and STAT5B
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Lothar Hennighausen1 and Gertraud W. Robinson Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA Transcription factors from the family of Signal Trans- the “wrong” STATs and thus acquire inappropriate cues. ducers and Activators of Transcription (STAT) are acti- We propose that mice with mutations in various com- vated by numerous cytokines. Two members of this fam- ponents of the JAK–STAT signaling pathway are living ily, STAT5A and STAT5B (collectively called STAT5), laboratories, which will provide insight into the versa- have gained prominence in that they are activated by a tility of signaling hardware and the adaptability of the wide variety of cytokines such as interleukins, erythro- software. poietin, growth hormone, and prolactin. Furthermore, constitutive STAT5 activation is observed in the major- ity of leukemias and many solid tumors. Inactivation Historical perspective studies in mice as well as human mutations have pro- In 1994, Bernd Groner and colleagues (Wakao et al. vided insight into many of STAT5’s functions. Disrup- 1994), then at the Friedrich Miescher Institute in Basel, tion of cytokine signaling through STAT5 results in a cloned a cDNA from lactating ovine mammary tissue variety of cell-specific effects, ranging from a defective that encoded a transcription factor promoting prolactin- immune system and impaired erythropoiesis, the com- induced transcription of milk protein genes in mammary plete absence of mammary development during preg- epithelium.
    [Show full text]
  • Mast Cell STAT6 IL-4 Induces the Proteolytic Processing Of
    IL-4 Induces the Proteolytic Processing of Mast Cell STAT6 Melanie A. Sherman, Doris R. Powell and Melissa A. Brown This information is current as J Immunol 2002; 169:3811-3818; ; of September 28, 2021. doi: 10.4049/jimmunol.169.7.3811 http://www.jimmunol.org/content/169/7/3811 Downloaded from References This article cites 74 articles, 47 of which you can access for free at: http://www.jimmunol.org/content/169/7/3811.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IL-4 Induces the Proteolytic Processing of Mast Cell STAT61 Melanie A. Sherman, Doris R. Powell, and Melissa A. Brown2 IL-4 is a potent, pleiotropic cytokine that, in general, directs cellular activation, differentiation, and rescue from apoptosis. However, in mast cells, IL-4 induces the down-regulation of activation receptors and promotes cell death.
    [Show full text]
  • Stats: Transcriptional Control and Biological Impact
    REVIEWS STATS: TRANSCRIPTIONAL CONTROL AND BIOLOGICAL IMPACT David E. Levy* and J. E. Darnell Jr‡ Extracellular proteins bound to cell-surface receptors can change nuclear gene expression patterns in minutes, with far-reaching consequences for development, cell growth and homeostasis. The signal transducer and activator of transcription (STAT) proteins are among the most well studied of the latent cytoplasmic signal-dependent transcription-factor pathways. In addition to several roles in normal cell decisions, dysregulation of STAT function contributes to human disease, making the study of these proteins an important topic of current research. SIGNALLING SH2 DOMAIN This year marks the tenth anniversary of the recogni- and transphosphorylation on tyrosine residues, releasing (Src-homology-2 domain). A tion of the STAT proteins, named after their dual role as their intrinsic catalytic activity. Tyrosine phosphoryla- protein motif that recognizes signal transducers and activators of transcription1–4. tion by activated JAKs of cytokine-receptor cytoplasmic and binds tyrosine- These transcription factors are latent in the cytoplasm domains then provides binding sites for the Src-homol- phosphorylated sequences, and thereby has a key role in relaying until they are activated by extracellular signalling pro- ogy-2 (SH2) DOMAIN of the STAT proteins. The STAT pro- cascades of signal transduction. teins (mainly cytokines and growth factors, but also teins are then recruited to the JAKs, whereupon they are some peptides) that bind to specific cell-surface recep- phosphorylated on a single tyrosine residue (around tors. These extracellular-signalling proteins can activate residue 700 of their 750–850-amino-acid sequence). various tyrosine kinases in the cell that phosphorylate Although the interactions and consequences of STAT STAT proteins.
    [Show full text]